Here are (3) very interesting articles dealing with prostate cancer.
We have a a chance at stopping the “dreaded chemo” as a main stream PCa cell killer. Some day we will be able to “smart Bomb” the PCa cells instead of “Carpet Bomb”, (Article #1). Article #2 & #3 deals with the fixing of clinical trials and the under playing of the need for PCa treatments.
1) No More Chemo: Doctors Say It’s Not So Far-Fetched
“There’s a revolution occurring in cancer treatment, and it could mean the end of chemotherapy. “It’s a question we are all asking,” says Dr. Martin Tallman, chief of the leukemia service at Memorial Sloan Kettering Cancer Center. “I think we are definitely moving farther and farther away from chemotherapy, and more toward molecularly targeted therapy.”
It’s the difference between carpet bombing and “smart bomb” strategies for leveling an enemy – in this case a fast-growing mass of cells that can strangle and starve surrounding normal tissues. Targeted therapies, as they are called, are aimed at specific pathways that tumor cells use to thrive, blocking them in the same way that monkeying with a car’s ignition, or it’s fuel intake, can keep it from running properly. The advantage of such precise strategies is that they leave healthy cells alone, which for patients means fewer side effects and complications”.
2) Building a Better Clinical Trial System
“It’s always been a bit of a puzzle to me that the government has pharmaceutical companies conduct clinical trials for new drugs. Oh, it’s not really that puzzling–clinical trials are very expensive, and having the companies do it keeps the cost of the trials off the government’s books. But this seems like false economy. No matter how ethical the pharmaceutical companies are–and I, for one, do not think that they are comic book supervillians eagerly poisoning their customers–the incentives are skewed. Pharmaceutical companies have a strong personal interest in not finding out that their drugs don’t work, or don’t work as well as competitors. That’s not their fault; it’s just the hard fact of human nature”.
3) Pricey prostate cancer treatments used on men who may not need them
“There continues to be pervasive over-treatment of men with low-risk prostate cancer who are very unlikely to benefit from such treatment, and who would be better served in many cases — likely in most cases — with active surveillance,” Matthew Cooperberg, assistant professor of urology at the Helen Diller Family Comprehensive Cancer Center, University of California San Francisco told NBC News. Despite new guidelines recommending “watchful waiting” for men diagnosed with prostate cancers that carry a low risk of death, more are undergoing potentially unnecessary, but expensive, treatment with high-tech machines according to a large study published Tuesday in the Journal of the American Medical Association (JAMA)”.
Your husband will hold your hand only for a little while…..But he will hold your heart for your life time!